Thank you for subscribing!
Finfeed Archived May 10, 2021
Bod Australia (ASX: BDA) today announced its highest ever monthly sales for its medicinal cannabis prescription products. BDA attributes its current growth to its Australia wide clinical study to test the efficacy of MediCabilis™ when prescribed for conditions including anxiety, insomnia, and Post Traumatic Stress Disorder (PTSD).
Get expert stock analysis direct in your inbox
Join Our Mailing List
